Next Article in Journal
Development and Antibacterial Activity of Cashew Gum-Based Silver Nanoparticles
Previous Article in Journal
Differential Protein Expression in Response to Abiotic Stress in Two Potato Species: Solanum commersonii Dun and Solanum tuberosum L.
Previous Article in Special Issue
ANRIL: Molecular Mechanisms and Implications in Human Health
Review

Non-Coding RNAs: Functional Aspects and Diagnostic Utility in Oncology

by and *,†
Nesher Technologies, Inc., 2100 W. 3rd St. Los Angeles, CA 90057, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2013, 14(3), 4934-4968; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms14034934
Received: 10 December 2012 / Revised: 9 February 2013 / Accepted: 18 February 2013 / Published: 1 March 2013
(This article belongs to the Special Issue Non-Coding RNAs)
Noncoding RNAs (ncRNAs) have been found to have roles in a large variety of biological processes. Recent studies indicate that ncRNAs are far more abundant and important than initially imagined, holding great promise for use in diagnostic, prognostic, and therapeutic applications. Within ncRNAs, microRNAs (miRNAs) are the most widely studied and characterized. They have been implicated in initiation and progression of a variety of human malignancies, including major pathologies such as cancers, arthritis, neurodegenerative disorders, and cardiovascular diseases. Their surprising stability in serum and other bodily fluids led to their rapid ascent as a novel class of biomarkers. For example, several properties of stable miRNAs, and perhaps other classes of ncRNAs, make them good candidate biomarkers for early cancer detection and for determining which preneoplastic lesions are likely to progress to cancer. Of particular interest is the identification of biomarker signatures, which may include traditional protein-based biomarkers, to improve risk assessment, detection, and prognosis. Here, we offer a comprehensive review of the ncRNA biomarker literature and discuss state-of-the-art technologies for their detection. Furthermore, we address the challenges present in miRNA detection and quantification, and outline future perspectives for development of next-generation biodetection assays employing multicolor alternating-laser excitation (ALEX) fluorescence spectroscopy. View Full-Text
Keywords: ncRNAs; miRNAs; biomarkers; cancers; SMD; ALEX ncRNAs; miRNAs; biomarkers; cancers; SMD; ALEX
Show Figures

Graphical abstract

MDPI and ACS Style

Kim, T.; Reitmair, A. Non-Coding RNAs: Functional Aspects and Diagnostic Utility in Oncology. Int. J. Mol. Sci. 2013, 14, 4934-4968. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms14034934

AMA Style

Kim T, Reitmair A. Non-Coding RNAs: Functional Aspects and Diagnostic Utility in Oncology. International Journal of Molecular Sciences. 2013; 14(3):4934-4968. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms14034934

Chicago/Turabian Style

Kim, Taiho, and Armin Reitmair. 2013. "Non-Coding RNAs: Functional Aspects and Diagnostic Utility in Oncology" International Journal of Molecular Sciences 14, no. 3: 4934-4968. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms14034934

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop